Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chung Jin Biotech is a South Korean biotechnology company specializing in the research, development, and commercialization of bee venom-based products. The company is a global leader in bee venom technology, utilizing a proprietary, non-lethal harvesting method that preserves bee welfare while ensuring high purity of the extracted venom. Their core business revolves around purified bee venom and its primary active component, melittin, which are used in pharmaceutical, cosmetic, and veterinary applications. In addition to biological products, the company manufactures specialized equipment such as bee venom collectors and fluid bed processors for pharmaceutical granulation and coating.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chunjin.